Pierre Gibert

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic.

ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA.

Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.

Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021.

Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA.

Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston.

EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed.

Gustave Roussy Transfert is a subsidiary of Gustave Roussy, the first cancer control center in France, which places innovation at the heart of care and research against cancer. The private company is based in Villejuif, France. The French company's main mission is to identify, protect, promote, and support the scientific, technological, and medical resources of Gustave Roussy. Gustave Roussy Transfert has designed a program called "Better Living Cancer" to support cancer patients during and after treatments through complementary approaches and practices to improve their quality of life. The program includes physical activity sessions, mindfulness meditation courses, and aesthetic care.

Part of PharmaEngine, Inc., Pharmaengine Europe SARL develops pharmaceutical products for cancer diseases. The company is based in Paris, France. The CEO of the French company is Alain Herrera.

eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France.

Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York.

Compas SA wholesales chemical products. The company was founded on April, 19 1949 and is headquartered in Gueux, France.

eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation.

French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France.

Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.

Action Against Hunger is a non-profit organization that works in 55 countries to address the root causes of hunger, including climate change, conflict, inequity, and emergencies. Action Against Hunger is based in Paris, France. With 8,990 dedicated staff members, it strives to create a world free from hunger for everyone. The organization is a leader in a movement that aims to end life-threatening hunger for good within our lifetimes. It served more than 17 million people in 2019 alone.

AMD Medicom, Inc. manufactures disposable medical supplies. It is engages in the manufacturing and distribution of infection control, single use, and preventive products for medical, dental, industrial, retail, veterinary and laboratory markets. The company was founded by Ronald Reuben in 1988 and is headquartered in Montreal, Canada.

Anapharm, Inc. is a hospital and health care company. It provides clinical trials and bioanalytical research services. The company is headquartered in Québec, Canada.

Medicom Group, Inc. is a Canadian company that manufactures and sells a variety of medical products including gloves, surgical blades, non-woven sponges, masks, sterilization and evacuation products. The private company is based in Lachine, Canada. and has subsidiaries in Germany. The company was founded in 1988 by Ronald Reuben. Laverdure Guillaume has been the CEO of the company since 2009.

Gustave Roussy Foundation is a leading European cancer center that specializes in the treatment of rare cancers and complex tumors. Gustave Roussy Foundation is located in Villejuif and Chevilly-Larue, France, and has 3,200 health professionals and 4,100 professionals working on its two campuses. The institute provides expert care for all cancers at every stage of life and caters to almost 50,000 patients per year. It is a source of diagnostic and therapeutic advances and integrates research, patient care, and teaching. The institute offers personalized management that combines innovation and a human-focused approach, taking into account care and physical, psychological, and social quality of life.

Alain Oncologie Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera.

Ad Bio Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera.